These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34262010)

  • 21. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report.
    Fujimiya T; Azuma K; Togashi Y; Kuwata K; Unezaki S; Takeuchi H
    J Pharm Health Care Sci; 2024 Feb; 10(1):10. PubMed ID: 38365819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S; Leiter A; Galsky M; Gallagher EJ
    J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case report of complication liked jejunal conduit syndrome induced by reconstruction of ileal conduit].
    Koba K; Furuya R; Taira H; Ishii T; Hiratsuka Y
    Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):630-3. PubMed ID: 15103928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated Adrenocorticotropic Hormone Deficiency and Primary Hypothyroidism in a Patient Undergoing Long-Term Hemodialysis: A Case Report and Literature Review.
    Ohara N; Kobayashi M; Tuchida M; Koda R; Yoneoka Y; Iino N
    Am J Case Rep; 2020 Apr; 21():e922376. PubMed ID: 32343680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated Adrenocorticotropic Hormone (ACTH) Deficiency as an Immune-Related Adverse Event Following Combination Immune Checkpoint Inhibitor Therapy.
    Matsushiro M; Shibue K; Osawa K; Hamasaki A
    Cureus; 2024 Jun; 16(6):e62863. PubMed ID: 39040756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.
    Ariyasu H; Inaba H; Ota T; Yamaoka H; Furukawa Y; Iwakura H; Doi N; Yamamoto Y; Akamizu T
    In Vivo; 2018; 32(2):345-351. PubMed ID: 29475919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperkalemia due to selective hypoaldosteronism.
    Arora KK; Pfeifer MA; Wolter C; Melo J; Samols E
    South Med J; 1977 May; 70(5):634-6. PubMed ID: 193197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review.
    Hashinokuchi A; Haro A; Minagawa R; Haruta Y; Kawano H; Suehiro T; Sugimachi K
    Cancer Diagn Progn; 2023; 3(4):498-503. PubMed ID: 37405219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse Endocrine-Related Effects of Pembrolizumab Precipitating Severe Hyponatremia.
    Baldawi MB; Dhami B; Gosai J; Al-Khafaji RH
    Cureus; 2022 Aug; 14(8):e28393. PubMed ID: 36171843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
    BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency.
    Ono M; Fukuda I; Nagao M; Tomiyama K; Okazaki-Hada M; Shuto Y; Kobayashi S; Yamaguchi Y; Nagamine T; Nakajima Y; Inagaki-Tanimura K; Sugihara H
    Pituitary; 2022 Aug; 25(4):615-621. PubMed ID: 35653047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary Adrenal Insufficiency Following Nivolumab Therapy in a Patient with Metastatic Renal Cell Carcinoma.
    Seki T; Yasuda A; Oki M; Kitajima N; Takagi A; Nakajima N; Miyajima A; Fukagawa M
    Tokai J Exp Clin Med; 2017 Sep; 42(3):115-120. PubMed ID: 28871578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab.
    Kedzior SK; Jacknin G; Hudler A; Mueller SW; Kiser TH
    Am J Case Rep; 2021 Jun; 22():e931702. PubMed ID: 34185763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient pseudo-hypoaldosteronism following resection of the ileum: normal level of lymphocytic aldosterone receptors outside the acute phase.
    Vantyghem MC; Hober C; Evrard A; Ghulam A; Lescut D; Racadot A; Triboulet JP; Armanini D; Lefebvre J
    J Endocrinol Invest; 1999 Feb; 22(2):122-7. PubMed ID: 10195379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pembrolizumab-Induced Isolated Adrenocorticotropic Hormone (ACTH) Deficiency
.
    Alfares K; Han HJ
    Cureus; 2024 Jan; 16(1):e52235. PubMed ID: 38352096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune checkpoint inhibitor-associated adrenal insufficiency in Chinese cancer patients: a retrospective analysis.
    Cai Q; Wu W; Li X; Xu Q; Zhao L; Lv Q
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):14113-14123. PubMed ID: 37553420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody.
    Matsuoka H; Hayashi T; Takigami K; Imaizumi K; Shiroki R; Ohmiya N; Sugiura K; Kawada K; Sawaki A; Maeda K; Ando Y; Uyama I
    BMC Cancer; 2020 Jul; 20(1):656. PubMed ID: 32664888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
    Beck TN; Kudinov AE; Dulaimi E; Boumber Y
    BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer.
    Nagai T; Mogami T; Takeda T; Tomiyama N; Yasui T
    Urol Case Rep; 2021 Nov; 39():101766. PubMed ID: 34285878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.